Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502125 · ClinicalTrials.gov registry record
In Vivo Confocal Imaging of Oral Mucosa
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 12
- Enrollment target
NCT00502125: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00502125 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00502125 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the feasibility of using reflectance confocal imaging to noninvasively detect and diagnose oral dysplasia and early carcinoma.
Interventions
- PROCEDURE Reflectance Confocal Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-01 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00502125
The ClinicalTrials.gov registry entry for NCT00502125 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reflectance Confocal Imaging is the first listed.
NCT00502125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00502125 about?
NCT00502125 is a clinical study titled "In Vivo Confocal Imaging of Oral Mucosa". The objective of this study is to evaluate the feasibility of using reflectance confocal imaging to noninvasively detect and diagnose oral dysplasia and early carcinoma.
What is the current status of trial NCT00502125?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2003-01. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00502125?
The interventions under investigation include: Reflectance Confocal Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00502125?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.